Rivaroxaban (Xarelto) in the management of stroke and DVT

S Chaplin, V Haunton, T Robinson, C Bagot

Research output: Contribution to journalArticlepeer-review

Abstract

<jats:title>Abstract</jats:title><jats:p>Rivaroxaban is now licensed for the prevention of stroke and the treatment and prevention of DVT. In our New products review, Steve Chaplin presents the clinical data for its efficacy and adverse events related to these new indications, and specialists comment on its likely place in therapy.</jats:p>
Original languageEnglish
Pages (from-to)14-23
Number of pages0
JournalPrescriber
Volume23
Issue number17
DOIs
Publication statusPublished - 5 Sept 2012

Fingerprint

Dive into the research topics of 'Rivaroxaban (Xarelto) in the management of stroke and DVT'. Together they form a unique fingerprint.

Cite this